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We have studied the role of N-linked oligosaccha- 
rides and proteolytic processing on the targeting of 
cathepsin D to the lysosomes in the human  hepatoma 
cell line HepGZ.  In the presence of tunicamycin cathep- 
sin D was synthesized as an unglycosylated 43-kDa 
proenzyme which was proteolytically processed via a 
39-kDa intermediate to a 28-kDa mature form. Only 
a small portion was secreted into the culture medium. 
During intracellular transport the 43-kDa procathep- 
sin D transiently became membrane-associated inde- 
pendently of binding to the mannose 6-phosphate 
receptor. Subcellular fractionation showed that ungly- 
cosylated cathepsin D was  efficiently targeted to the 
lysosomes via intermediate compartments similar to 
the enzyme in control cells. The results show that in 
HepGZ cells processing and transport of cathepsin D 
to the lysosomes is independent of mannose 6-phos- 
phate residues. 
Inhibition of the proteolytic processing of 53-kDa 
procathepsin D by protease inhibitors caused this form 
to accumulate intracellularly. Subcellular fractiona- 
tion revealed that the procathepsin D was transported 
to lysosomes, thereby losing its membrane association. 
Procathepsin D taken up  by the mannose 6-phosphate 
receptor also transiently became membrane-associ- 
ated, probably in the same compartment. We conclude 
that the mannose 6-phosphate-independent mem- 
brane-association is a transient and compartment-spe- 
cific  event in the transport of procathepsin D. 
Cathepsin D is a major lysosomal aspartyl protease in 
mammalian cells. Like other soluble lysosomal enzymes, the 
glycoprotein is synthesized in the rough endoplasmic reticu- 
lum and subsequently provided with mannose-linked  phos- 
phate residues on the N-linked oligosaccharides. These man- 
nose 6-phosphate (Man-6-P)’ residues are  then recognized by 
mannose phosphate receptors (MPR), of which two types 
have been identified. After binding to MPR in the Golgi 
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complex cathepsin  D is targeted to a prelysosomal compart- 
ment where it is released from the  MPR due to  the acidic 
environment (Von Figura and Hasilik, 1986; Kornfeld and 
Mellman, 1989). 
In addition to  this efficient receptor system, several lines 
of evidence indicate that MPR-independent  targeting of sol- 
uble lysosomal enzymes to lysosomes exists. Generally, if the 
phosphorylation mechanism is defective, precursors of soluble 
lysosomal enzymes fail to be recognized by the MPR and 
consequently are secreted. This is observed in fibroblasts of 
patients suffering from I-cell disease (Hasilik and Neufeld, 
1980). However, in some cell types and tissues of these pa- 
tients, including hepatocytes, soluble lysosomal enzymes like 
cathepsin D are  targeted to  the lysosomes independent of the 
MPR (Owada and Neufeld, 1982; Neufeld and McKusik, 1983; 
Kornfeld, 1986; Nolan and Sly, 1989). In addition, transport 
of lysosomal membrane proteins to the lysosomes is unaf- 
fected in the absence of N-linked oligosaccharides, indicating 
their independence of MPR (Barriocanal et al., 1986;  Croze 
et al., 1989). An intermediate position is observed in  the case 
of the lysosomal enzyme glucocerebrosidase (Barranger and 
Ginns, 1989). Glucocerebrosidase is synthesized as a soluble 
protein but  it becomes associated to cellular membranes dur- 
ing its  transport  to  the lysosomes (Rijnboutt et al., 1991). The 
protein does not acquire Man-6-P residues (Aerts et al., 1988) 
and must  therefore be targeted to  the lysosomes independ- 
ently of the  MPR. Two separate  studies have provided evi- 
dence that  the proenzyme of cathepsin D can also be mem- 
brane-associated.  Diment et al. (1988) found that procathep- 
sin D is membrane-associated in the endosomes of rabbit 
macrophages and that this interaction is not mediated by 
Man-6-P. The membrane association disappeared concomi- 
tantly with proteolytic processing of the proenzyme. Similar 
results were obtained for cathepsin D and sphingolipid-acti- 
vating  protein  in HepG2 cells where membrane association of 
the proenzymes occurred in or  just distal to  the Golgi complex 
(Rijnboutt et al., 1991). The membrane association was de- 
tected after differential permeabilization of the cells with 
saponin,  a cholesterol complexing agent (Schlbser  and Wulff, 
1969; Bangham and Horne, 1962). Differential permeabiliza- 
tion with saponin can selectively release secretory proteins 
but  not membrane  proteins (Wassler et al., 1987; Strous  and 
Van Kerkhof, 1989). 
In  this study we have used tunicamycin, an inhibitor of N- 
linked glycosylation, in combination with the differential 
permeabilization of cells with saponin. Our results with tun- 
icamycin indicate that membrane association and  transport 
of cathepsin D to  the lysosomes was not dependent on the 
presence of N-linked oligosaccharides in HepGZ cells. In 
addition, we have used protease inhibitors to inhibit the 
proteolytic processing of cathepsin  D  in order to define the 
membrane association process as a sorting phenomenon (Von 
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FIG. 1. Biosynthesis of cathepsin D in HepG2 cells in the 
absence or presence of tunicamycin. A, biosynthesis of cathepsin 
D. Cells  were metabolically labeled with [36S]methionine for 15 min 
and chased for the times indicated (h). Cells  were immediately solu- 
bilized after the chase period and cathepsin D was immunoprecipi- 
tated from the lysates as well as  the culture media and analyzed on 
SDS-PAGE. Relative molecular mass standards  are indicated on the 
right. B, Cells were labeled as in A except that 4 h prior to and 
throughout the pulse-chase-labeling procedure, 10 pg/ml tunicamycin 
was present. (Note that all metabolic forms of unglycosylated cathep- 
sin D had lower molecular weights compared with cathepsin D from 
control cells.) C, experiment similar to  that presented in E except 
that after the chase period the cells were differentially permeabilized 
with saponin in the absence (left) or presence (right) of Man-6-P. D, 
Figura et al., 1983; Hentze et al., 19W, Steckel et al., 1985; 
Gieselmann et al., 1985; Hanewinkel et al., 1987;  Samarel et 
al., 1989). We show that in the presence of the protease 
inhibitors E64 and pepstatin the Man-6-P-independent mem- 
brane association of procathepsin D was lost during the 
transport of procathepsin D to the lysosomes, indicating a 
compartment-specific  process. 
MATERIALS AND  METHODS 
Metabolic  Labeling and Permeabilization of  CeUs-The human hep- 
atoma cell line HepG2 (Knowles et al., 1980)  was cultured in mono- 
layer as described previously (Rijnboutt  et al., 1991). Human foreskin 
fibroblasts were cultured and labeled identically to the HepG2  cells. 
HepG2 cells were  grown on 35-mm Petri dishes, washed with phos- 
phate-buffered saline (PBS) and preincubated in Eagle's minimal 
essential medium without methionine (Gibco Laboratories). Cells 
were then labeled for 15 min with 60 pCi/ml [=S]methionine (800- 
1200 Ci/mmol, Radiochemical Center, Amersham, United Kingdom) 
and chased for various periods of time in 1 ml of the culture medium. 
In some experiments the culture medium  was supplemented with 10 
pg/ml tunicamycin (Boehringer, Mannheim) or  the protease inhibi- 
tors E64, leupeptin, and pepstatin, each at  a final concentration of 
100 FM. Stock solutions of tunicamycin (1 mg/ml) were prepared in 
0.01 mM NaOH, leupeptin (10 mM) in water, pepstatin (10 mM) in 
dimethyl sulfoxide, and E64 (10 mM) in 50% ethanol. These solvents 
themselves had no effect on the targeting and maturation of cathepsin 
D. Metabolic labeling of the cells in the presence of tunicamycin or 
protease inhibitors was preceded by a preincubation of the cells with 
the reagent for 4 or 3 h, respectively, and all  further incubations were 
done in the presence of the drug(s). For differential permeabilization 
(Strous and van Kerkhof, 1989; Rijnboutt et al., 1991), cells were kept 
on ice, washed with ice-cold PBS, and incubated in 1 ml of PBS 
containing 2 mg/ml saponin (Merck) for 30 min on a rocking plat- 
form. After 30 min the saponin-containing medium was removed and 
cells were washed with PBS. Further washing or repeating the saponin 
incubation did not result  in an additional release of the membrane- 
associated procathepsin D. The cells finally were  solubilized in 1 ml 
of PBS containing 1% Triton X-100 and 1 mM phenylmethylsulfonyl 
fluoride. Aliquots of the cell extracts and culture media  were  used for 
immunoprecipitation of cathepsin D as described previously 
(Rijnboutt et al., 1991). The fluorog-rams  of the gels  were quantitated 
by scanning full lanes in an LKB Ultroscan XL enhanced laser 
densitometer. 
Glycanase F Digestion-After immunoprecipitation, immune com- 
plexes were dissociated by incubation for 5 min at  90 "C in 100 p1 of 
1% SDS. Samples were then divided into two aliquots. Digestion of 
immunoprecipitated cathepsin D with or without 0.3 units/incubation 
N-glycanase F (Boehringer, Mannheim) was performed for 18 h at  
37  "C in  sterile 0.1 M sodium citrate buffer, pH 6.0, containing 1 mM 
EDTA, 0.2% SDS, 0.5% Triton X-100, and 1 mM phenylmethylsul- 
fonyl fluoride. Subsequently, samples were subjected to SDS-PAGE 
and fluorography. 
Cell Fractionation and Sucrose Density Gradient Centrifugation- 
HepG2 cells were  grown on 9-cm Petri dishes and pulse-chase-labeled 
for 10 min with [%S]methionine as described above.  Cells  were  washed 
with ice-cold PBS and harvested by scraping in 1 ml  of buffer 
containing 10 mM HEPES, 15 mM KCI, and 1.5 mM M&h. Cells 
were  homogenized in 50 strokes in a Dounce homogenizer with a tight 
fitting  pestle  (Kontes Glass Co., Vineland, NJ).  The homogenate was 
centrifugated for 5 min at  300 X g to remove  nuclei. 750 pl of the 
postnuclear supernatant was layered on top of a linear gradient (11 
ml, 0.7-1.6 M sucrose, 20 mM Tris, pH 7.5, and 1 mM EDTA). 
Intracellular compartments were separated by centrifugation in a 
Beckman ultracentrifuge at  100,000 X g using a SW 41 rotor for 3 h 
at  4 "C. Subsequently, fractions were immunoprecipitated in the 
presence of 0.5% Triton X-100 and subjected to SDS-PAGE. For 
unlabeled cells, aliquots of the fractions were  analyzed by Western 
blotting. 
N-glycanase F digestion of immunoprecipitated cathepsin D. At the 
two chase times indicated cathepsin D species synthesized in the 
absence or presence of 10 pg/ml tunicamycin ( 2 " )  as in A and B 
were each digested with N-glycanase F as described under "Materials 
and Methods" and analyzed by SDS-PAGE. 
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RESULTS branes were fully retained  (Wassler et al., 1987; Strous  and 
Membrane  Association  Is  Independent of N-Linked Glyco- 
sylation-In HepG2 cells (Fig. 1A) and human fibroblasts 
(Fig. 2) cathepsin D is synthesized as a 51-kDa precursor 
which is  converted  to  the  53-kDa species within 1 h. Most of 
the 53-kDa  species is then processed via the  44-kDa species 
to  the  mature  31-kDa form within 3  h.  Only  a small  percentage 
of the 53-kDa procathepsin D is secreted. This sequence of 
events  has been reported for  several other cell types  (Hasilik 
and Neufeld, 1980; Erickson et al., 1981; Rosenfeld et al., 1982; 
Gieselmann et  al., 1983). When  fibroblasts were treated  with 
tunicamycin, a drug which specifically inhibits  N-linked gly- 
cosylation thus  preventing  phosphorylation of mannose resi- 
dues, newly synthesized unglycosylated procathepsin D is 
completely secreted (Fig. 2),  as was found for cathepsin D and 
other soluble lysosomal proenzymes  (Von  Figura et al., 1979; 
Erickson et  al., 1981; Rosenfeld et  al., 1982; Imort et  al., 1983; 
Hanewinkel et  al., 1987; Nishimura et al., 1988a,  1988b). This 
would be expected if Man-6-P  is  the only  lysosomal targeting 
signal  for cathepsin D. However, cathepsin D  in  HepG2  cells 
behaved  differently. If these cells were labeled  in the  presence 
of tunicamycin the  resulting 43-kDa precursor was  normally 
processed into a 39-kDa  intermediate  within 2  h and  into a 
28-kDa "mature enzyme" after 3 h. Neither significant in- 
crease of secretion nor  degradation of unglycosylated proca- 
thepsin D was observed  in  HepG2 cells (Fig. 1B).  To  deter- 
mine whether the inhibition of N-linked glycosylation of 
cathepsin D in HepG2 cells was complete, we incubated 
cathepsin D  synthesized in  the presence of tunicamycin  with 
N-glycanase F. This enzyme removes N-linked oligosaccha- 
rides from glycoproteins regardless of their complexity. No 
further decrease of the  apparent molecular weight was de- 
tected (Fig. 1D).  Cathepsin  D,  immunoprecipitated from con- 
trol cells, could be deglycosylated to a  species with an  apparent 
molecular weight similar  to  the  cathepsin D synthesized  in 
the presence of tunicamycin (Fig. ID). We conclude that 
tunicamycin  completely inhibits  the glycosylation of cathep- 
sin D. 
Since  unglycosylated procathepsin D is unable  to  bind  to 
the  MPR, presumably another  kind of membrane association 
is required to  retain  the unglycosylated  proenzyme in  intra- 
cellular compartments. In a previous study we established 
that during  its  intracellular  transport  53-kDa  procathepsin D 
becomes membrane-associated (Rijnboutt et al., 1991). In 
these  experiments we used low concentrations of the choles- 
terol-complexing agent  saponin  to differentially  permeabilize 
HepG2 cells. Under these conditions soluble proteins were 
rinsed out completely, whereas proteins attached to mem- 
Van Kerkhof, 1989; Rijnboutt et al., 1991). To  examine 
whether  the observed membrane association of procathepsin 
D is related to the observed maturation of unglycosylated 
cathepsin D, pulse-chase-labeled cells were differentially per- 
meabilized with saponin. As seen in Fig. lC,  the (unglycosyl- 
ated) 43-kDa cathepsin D  species  became  membrane-associ- 
ated  during  the  chase period as was previously found for the 
glycosylated procathepsin D. This association disappeared 
concomitantly with the  appearance of the 39-kDa unglycosyl- 
ated  intermediate. If 10 mM Man-6-P was added to the 
saponin  no  additional  procathepsin D  was  released, indicating 
that  the  membrane association of the 43-kDa procathepsin D 
was Man-6-P-independent. This concentration of Man-6-P 
has been shown to be sufficient to release all MPR-bound 
procathepsin D  from the cells (Rijnboutt et al., 1991). 
We next  studied  whether unglycosylated cathepsin D  can 
reach  the lysosomes. Therefore,  HepG2 cells were fractionated 
on sucrose density  gradients  after pulse-chase  labeling  in the 
absence  or presence of tunicamycin.  Cathepsin D was immu- 
noprecipitated from the fractions and analyzed by SDS- 
PAGE.  The  distribution of the various  species of cathepsin D 
from control cells after 3  h of chase shows that  the 53-kDa 
intermediate was found in  fractions 9-11, whereas the 44-kDa 
form was present  in  fractions of slightly  higher densities (Fig. 
3A).  The  31-kDa  mature form cofractionated with the lyso- 
somal  marker /3-hexosaminidase near  the  bottom of the  tube 
(fractions 4-9). The  distribution of the completely unglyco- 
sylated  mature  cathepsin D, synthesized  in  the presence of 10 
pg/ml tunicamycin (Fig. 3C, fractions 4-9), shows that  ca- 
thepsin D  was targeted  to  the lysosomes independent of the 
presence of N-linked oligosaccharides. This  is also illustrated 
in Fig. 3B, where intermediates of both normally glycosylated 
and unglycosylated cathepsin D are  synthesized at   the same 
time due to the use of an  intermediate concentration of 
tunicamycin (5 pg/ml). In this gradient related species of 
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sucrose density gradients. HepG2 cells were labeled with ['''SI 
methionine  as  in Fig. 1 and  chased  for 3 h. In A no  drug  was  added. 
FIG. 2. Biosynthesis of cathepsin D in fibroblasts. Human In R and C cells were treated with 5 and 10 pg/ml tunicamycin, 
skin fibroblasts were pulse-labeled with ["Slmethionine in the ab- respectively. The cells were then homogenized and fractionated by 
sence or the presence of 10 pg/ml tunicamycin identically to HepG2 sucrose-density centrifugation. Subsequently, cathepsin D was im- 
cells in Fig. 1. Cells were chased for the times indicated (h). After munoprecipitated from the fractions and subjected to SDS-PAGE. 
solubilization  aliquots of the cells and  the  culture media  were  immu- The enzymatic  activity of galactosyltransferase  (Strous  and Rerger, 
noprecipitated  for  cathepsin  D  and  analyzed by SDS-PAGE.  1982),  a Golgi marker  enzyme,  was  present  in  fractions 7-9. 
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control  and unglycosylated cathepsin D have  the  same  distri- 
bution so that  they probably  use identical  intracellular com- 
partments while routed  to  the lysosomes. Using  Western  blot 
analysis with unlabeled cells, which were incubated in the 
presence of 10 pg/ml tunicamycin for 7  h, the unglycosylated 
28-kDa  mature form cofractionated  with  the  pre-existing 31- 
kDa  mature form in  fractions 6-9, indicating  the 28-kDa  form 
had been targeted  to  the lysosomes (not  shown). 
Effect of Protease Inhibitors on Membrane Association- 
Our previous study on normally glycosylated cathepsin D 
(Rijnboutt  et al., 1991) together  with  the  present  data  obtained 
with tunicamycin (Fig. 1) suggests that the Man-6-P-inde- 
pendent membrane association of cathepsin D ends after 
proteolytic processing of the  precursor  proteins. To  investi- 
gate  this, HepG2 cells were pulse-chase-labeled in  the  pres- 
ence of two protease  inhibitors.  In  the  presence of both E64, 
a specific and irreversible inhibitor of cysteine  proteases,  and 
pepstatin,  an  inhibitor of aspartyl  proteases,  the  proteolytic 
processing of the 53-kDa procathepsin D  was inhibited  caus- 
ing accumulation of procathepsin D intracellularly (Fig. 4B). 
Both  protease  inhibitors  have previously been  shown to  in- 
hibit proteolytic processing and degradation of lysosomal 
enzymes (Hentze  et al., 1984; Richardson et al., 1988; Samarel 
et  al., 1989). Only after 3  h of chase a slight decrease to  an 
unusual molecular mass of 47-kDa was detectable. Fig. 4B 
shows that  the  membrane association of the 53-kDa proca- 
thepsin D increased due to accumulation of this form as 
detected by differential permeabilization of the cells with 
saponin  in  the presence of Man-6-P. Approximately 20% of 
the 53-kDa procathepsin  remained  membrane-associated a t  
each  chase  time  after  incubation  with  saponin i  the presence 
of Man-6-P, as was estimated after fluorogram scanning. 
Concomitantly,  the 47-kDa  form had  lost  its  membrane  as- 
sociation, In  control cells (Fig. 4A), the  protease  inhibitors 
had  no effect on  the  amount of secretion of procathepsin D 
into the culture medium (Fig. 4B). Identical results were 
obtained when  E64 was replaced  by leupeptin,  another  inhib- 
cnntml 
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itor of cysteine proteases  (data  not  shown). 
The conversion of the 53-kDa procathepsin D to  the 47- 
kDa intermediate form could be due to  either oligosaccharide 
or proteolytic processing. To determine this cathepsin D, 
synthesized in the  absence  or  the presence of protease  inhib- 
itors, was  digested with glycanase F to remove all N-linked 
oligosaccharides. Both  the 53- and  the 47-kDa forms of ca- 
thepsin D synthesized in the presence of E64 and  pepstatin 
were converted  to  the  same form with  an  apparent molecular 
mass of 43  kDa (Fig. 5B). All cathepsin D forms from control 
cells detected  after digestion  with  glycanase F were identical 
to those found in  the  tunicamycin  experiment  (compare Figs. 
5A and 1D). Thus,  the 47-kDa  form  which had accumulated 
in  the presence of protease  inhibitors  has  the  same peptide 
backbone as  the 53-kDa procathepsin  D,  and  the difference 
in  apparent molecular mass was due  to modifications  in the 
N-linked oligosaccharides. 
To  determine which compartments are involved in the 
processing and  transport of the  different metabolic forms of 
cathepsin D we performed  subcellular fractionation of pulse- 
chase-labeled cells on sucrose gradients as in Fig. 3. Cells 
were pretreated  with E64 and  pepstatin  as described above, 
pulse-labeled with  [“S]methionine for  30 min,  and chased  for 
4 h, both  in presence of the drugs. When cathepsin D was 
synthesized in the presence of E64 alone, an incomplete 
inhibition of the proteolytic processing was observed (Fig. 
6B), showing the  distribution of all metabolic forms in the 
same  gradient.  Biosynthesis  in  the presence of E64 did not 
change  the  distribution of the  53-kDa  procathepsin D (Fig. 
6B, fractions 9-12). The  47-kDa  form of the  procathepsin D 
codistributed  with  the 44-kDa intermediate form and  the 31- 
kDa lysosomal form (fractions 4-7) ,  indicating  that  the 47- 
kDa form  had been translocated  to  the lysosomal compart- 
ment. If leupeptin was  used instead of E64  a similar  distri- 
bution of cathepsin D  was obtained  (not  shown).  The presence 
of E64 caused the localization of the 44- and 31-kDa  forms to 
shift to a slightly higher density as compared with their 
distribution  in  control cells (Figs. 6A and 3A). In  an identical 
experiment  in which unlabeled cells were treated with E64 
for  4  h, all of the  pre-existing 31-kDa form, synthesized before 
E64 administration, behaved  in  a manner identical to  that of 
control 
0 I 2 3 4 h 
t - t - t - t - t N-glycnnnse F 
c 46 
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FIG. 4. Inhibition of the  proteolytic  processing of cathepsin 
D by E64 and pepstatin. A, control cells were  pulse-chase-labeled FIG. 5. N-Glycanase F digestion of cathepsin D synthesized 
for  times  indicated  as  in Fig. 1A. Differential  permeabilization of the in  the presence of E64 and pepstatin. Immunoprecipitated ca- 
cells  with  saponin  in the  presence of Man-6-P was  performed  on ice thepsin  D  from  control  cells ( A )  and  from  cells grown in the presence 
as described  under  “Materials  and  Methods.” R,  as in A except that  of 100 PM E64  and 100 PM pepstatin as in Fig 4R ( R )  was  digested 
cells were preincubated  for 3 h and  pulse-chase-labeled  in  presence with  N-glycanase F as described  under  “Materials  and  Methods”  and 
of E64 and  pepstatin. subsequently  analyzed by SDS-PAGE. 
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FIG. 6. Subcellular fractionation of cathepsin D on linear 
sucrose density gradients after inhibition  of  the  proteolytic 
processing. HepG2  cells were preincubated  for 3 h  with  or  without 
protease inhibitors, labeled with [""Slmethionine as  in Fig. 1, and 
chased  for  4  h.  In A no  drug  was  added.  In R and C cells  were  treated 
with  100 pM E64  alone  or  100 pM E64  and  100 pM pepstatin, 
respectively. The cells  were then homogenized, and  the  homogenate 
was fractionated by centrifugation. Subsequently, cathepsin D was 
immunoprecipitated  from  the  fractions  and  subjected  to  SDS-PAGE. 
The  enzymatic  activity of galactosyltransferase  (Strous  and  Berger, 
1982),  a Golgi marker  enzyme,  was  present  in  fractions 7-9. 
the newly synthesized 31-kDa in Fig. 6B  (data  not  shown). 
This  result confirmed that E64  slightly increases  the  density 
of lysosomes, again demonstrating  that  the newly synthesized 
47-, 44-, and 31-kDa forms were properly targeted to lyso- 
somes. This  experiment shows that  the presence of E64 and 
pepstatin caused  a  complete inhibition of proteolytic process- 
ing of procathepsin D as  seen before (Figs. 4B and 5 B )  but 
did  not  alter  the  distribution of the 53- and  47-kDa  forms 
(Fig. 6C). From these  fractionation  studies  it  is  clear  that  the 
procathepsin D is  transported  to  the lysosomes in  the  absence 
of proteolytic processing. Its  arrival  in  the lysosomes is  mon- 
itored by the conversion of the molecular mass from 53  to 47 
kDa due to modifications on  the  N-linked oligosaccharides. 
Thus, we conclude that  MPR-independent  membrane  asso- 
ciation  is  independent of removal of the  propeptide  and  only 
occurs in  a light  density organelle. 
Endocytosed Procathepsin D Becomes Membrane-associ- 
ated-Finally we examined  whether exogenously added  pro- 
cathepsin D also passes through a membrane association 
phase. ["SIMethionine-labeled procathepsin D, synthesized 
and secreted by HepG2 cells grown in the presence of 10 mM 
NH,Cl, was collected and added to unlabeled HepG2 cells 
(Fig. 7). Uptake was performed exclusively by the  MPR,  since 
addition of 10 mM Man-6-P  to  the  uptake medium  completely 
prevented uptake of ["S]methionine-labeled cathepsin D. 
(Fig. 7).  The  procathepsin D was efficiently  processed to  the 
44-kDa  intermediate form within 1 h and  subsequently proc- 
essed to the 31-kDa mature form after 2 h. Differential 
permeabilization  with saponin showed that all of the 53-kDa 
form was associated with cellular membranes, whereas the 
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FIG. 7. Proteolytic  processing and membrane association of 
endocytosed procathepsin D. HepG2  cells  were  incubated at  37 ' C  
for  times  indicated wit.h Eagle's minimal  essential  medium  containing 
"S-labeled  procathepsin D, supplemented  with 1 mg/ml  bovine  serum 
albumin.  Cells  were  then  washed  and  incubated  on ice with PBS ( A ) ,  
PRS  containing  saponin ( R ) ,  or PBS  containing  saponin  and  Man- 
6-P (C ) .  In D uptake via the  MPR was  prevented by addition of 5 
mM Man-6-P  to  the  uptake medium.  Subsequently,  cells were washed 
with PBS and lysed in  PBS-l%  Triton X-100.  Aliquots were immu- 
noprecipitated  for  cathepsin D and  analyzed by SDS-PAGE. 
44- and 31-kDa forms could be completely  rinsed out  during 
the  incubation with saponin. Addition of 10 mM Man-6-P  to 
the  saponin  solution caused  only part of the  membrane asso- 
ciated  material  to be rinsed  out. Surprisingly, part of the 53- 
kDa  procathepsin D had become membrane-associated inde- 
pendently of Man-6-P.  This  indicated  that  the  compartment 
in which the  Man-6-P-independent  membrane association of 
newly synthesized lysosomal enzymes  occurs is also accessible 
to  procathepsin  D, which had been  endocytosed by the  MPR. 
DISCUSSION 
Several studies have  shown that in most cells in the  pres- 
ence of tunicamycin (Von  Figura et al., 1979; Erickson et al., 
1981; Rosenfeld et al., 1982; Imort  et al., 1983; Nishimura  et 
al., 1988a, 198813) or  in  the presence of weak bases  (Wiesmann 
et al., 1975; Hasilik and Neufeld, 1980; Gonzalez-Noriega et 
al., 1980; Dean et al., 1984) all newly synthesized soluble 
lysosomal enzymes,  including cathepsin D, are secreted into 
the  culture medium without proteolytic processing. Our re- 
sults show that  in  HepG2 cells  unglycosylated cathepsin D is 
targeted  to  the lysosomes instead of being  secreted. Therefore, 
we conclude that  HepG2 cells possess an  alternative  targeting 
system  for  cathepsin D, which is  not  dependent  on  the pres- 
ence of Man-6-P residues. This  alternative  transport mecha- 
nism probably acts in the  same  compartments  as  the  MPR  as 
indicated by the subcellular fractionation  experiment.  Prote- 
olytic processing of the unglycosylated cathepsin D is as 
efficient as the processing of cathepsin D in control cells. 
This  alternative  targeting system has sufficient  capacity  for 
all newly synthesized  cathepsin D to  arrive in the lysosomes 
under conditions where targeting by MPR  has been elimi- 
nated. 
During  the  intracellular  transport  the unglycosylated pro- 
cathepsin D becomes membrane-associated. This  membrane 
association is likely part of the  alternate  targeting system for 
cathepsin D. We  previously reported  that  the proenzyme for 
glycosylated cathepsin D, but also the  precursors for gluco- 
cerebrosidase and sphingolipid activating  protein,  are initially 
present  as soluble proteins  in  the rough endoplasmic  reticu- 
lum  but become membrane-associated  as  they  arrive in the 
Golgi complex (Rijnboutt et dl., 1991). The mechanism in- 
volved for the  Man-6-P-independent  membrane association 
is unclear. To  study  the  nature of the interaction we have 
tried  to  find  conditions in  which  dissociation of procathepsin 
D  from the  membranes would occur by changing the condi- 
tions for semipermeabilization of the cells. Procathepsin D 
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was released from the membranes neither by incubation at 
pH values between 4 and 9, nor at ionic strengths varying 
between 0.05 and 1 M NaC1, nor using combinations of low 
pH and high ionic strength.* Only the detergent  Triton X- 
100, which solubilizes membranes completely, could release 
membrane-associated cathepsin D. Because the membrane 
association responsible for sorting soluble lysosomal enzymes 
is operative in a few distinctive cell types, it is likely that 
these cells contain  a specific class of membrane proteins or 
lipids used for this  sorting  in  a post-Golgi compartment. The 
spatial conformation of the procathepsin D could also be of 
importance with respect to  the membranes association. Di- 
ment et al. (1988) reported that  the membrane association 
observed for procathepsin D  in  rabbit macrophages is present 
in endosomes and disappears upon proteolytic processing in 
a later prelysosomal compartment. This indicated that  the 
peptide fragment which is proteolytically removed from 53- 
kDa procathepsin D to form the 44-kDa form was probably 
involved in the membrane interaction. Our experiments with 
protease inhibitors show that proteolytic processing is not  a 
prerequisite for the dissociation of procathepsin D from the 
membranes, since the 47-kDa form was not membrane-asso- 
ciated. Therefore, the  transient membrane association rather 
than proteolytic processing of procathepsin D  or the presence 
of the propeptide probably plays a role in the targeting to 
lysosomes. Several other  studies have indicated that  the  trans- 
port of lysosomal proenzymes to lysosomes is  not dependent 
on proteolytic processing (Oude Elferink et al., 1985; Samarel 
et al., 1989). In contrast,  in Dictyostelium  discoideum (Rich- 
ardson et al., 1989) and Xenopus oocytes (Opresko and Karpf, 
1987) inhibition of the proteolytic processing causes lysosomal 
proenzymes to accumulate prelysosomally. 
Subcellular fractionation showed that both Man-6-P-de- 
pendent and -independent membrane associations are re- 
stricted to  the same light density compartments  (Rijnboutt et 
al., 1991). The only membrane-associated form  of cathepsin 
D fractionates in a distinct peak, suggesting a single com- 
partment.  The non-membrane-associated procathepsin  D is 
probably secreted from this  compartment. The biosynthetic 
studies indicate that  the compartment is reached within 30 
min by newly synthesized procathepsin D. Therefore, it is 
likely that  the mannose 6-phosphate-independent membrane 
association starts in the Golgi-complex and is maintained 
until the procathepsin D reaches a prelysosomal compart- 
ment. Cathepsin D dissociates from the membrane before the 
degradation of the N-linked oligosaccharides starts, i.e. prob- 
ably before, entering the lysosome. Procathepsin D, taken  up 
via MPR, becomes membrane-associated independently of 
the MPR, suggesting that  the compartment in which  newly 
synthesized cathepsin  D becomes membrane-associated is also 
part of the endocytic pathway. This was also indicated in  the 
studies of Diment et al. (1988) which  showed that  the mem- 
brane-associated procathepsin D is accessible to lactoperoxi- 
dase. Taken together, these observations suggest a  compart- 
ment which has the characteristics of the trans-Golgi-reticu- 
lum or endosomes (Geuze and Morrk, 1991). 
The alternate targeting system present in HepG2 cells 
might represent the system responsible for transport of solu- 
ble  lysosomal enzymes to lysosomes in tissues of patients with 
I-cell disease. This disorder is caused by a deficiency of 
phosphotransferase activity which results in an inability to 
synthesize the Man-6-P recognition signal. However, Some 
tissues of patients with I-cell disease contain normal levels of 
soluble lysosomal enzymes, although the phosphotransferase 
S. Rijnboutt, A. J. Kal, H. J. Geuze, H. Aerts, and G. J .  Strous, 
unpublished results. 
is absent  in  these tissues. This indicates the existence of an 
alternative targeting mechanism, different from the MPR 
system in these tissues (Owada and Neufeld, 1982; Neufeld 
and McKusik, 1983; Nolan and Sly, 1989; Kornfeld, 1986). 
Furthermore, the alternative mechanism of lysosomal  enzyme 
targeting  in HepG2 cells is reminiscent of that found in D. 
discoideum,  where a mannose-phosphate-independent mem- 
brane association of lysosomal proenzymes is involved in 
transport to lysosomes (Mierendorf et al., 1985; Cardelli et al., 
1986). Similar to our observations in HepG2 cells, the mem- 
brane association in  the slime mold disappeared upon prote- 
olytic processing (Richardson et al., 1989; Cardelli et al., 1989). 
However, when the proteolytic processing of lysosomal en- 
zymes was prohibited with protease inhibitors, the proen- 
zymes  were secreted instead of being targeted to lysosomes as 
is shown in our present  study (Richardson et al., 1989). These 
authors have suggested that  this is due to  an overloading of a 
putative receptor for lysosomal targeting  in D. discoideurn, a 
process which apparently does not occur in HepG2  cells. 
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